Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Trial pipeline

Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.

Free access · No subscription for research tools or data exports

Filter the development pipeline

Reset

5 trials match this view; 5 reported facilities; 5 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 72 across 5 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

20231
20242
20252

Current indexed registry status

Completed3
Active, not recruiting1
Recruiting1

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Milestones to investigate

The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.

For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.

Matching trial records

5 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants

NCT06326606

Healthy Volunteers
MycoMedica Life Sciences PBC

PHASE1

Completed

Registry updated 2024-10-09

24

ACTUAL

2024-03-27
2024-07-08
2024-07-08
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants

NCT06643637

Healthy Volunteers
MycoMedica Life Sciences PBC

PHASE1

Completed

Registry updated 2025-06-12

16

ACTUAL

2024-11-08
2025-03-12
2025-03-12
Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-sampling

NCT05698511

Psychedelic Experiences · Neuroimaging · Healthy Volunteers
Robin Carhart-Harris, PhD, MA

PHASE1

Active, not recruiting

Registry updated 2026-06-05

12

ESTIMATED

2023-07-31
2026-01-30
2027-01-30
Open Label Psilocybin Brain Stimulation and Imaging Pilot Study

NCT06835699

Healthy Volunteers
Johns Hopkins University

PHASE1

Completed

Registry updated 2026-08-07

10

ACTUAL

2025-04-18
2026-05-21
2026-05-21
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers

NCT07079930

Healthy Volunteers
Hadassah Medical Organization

PHASE1

Recruiting

Registry updated 2026-02-05

10

ESTIMATED

2025-12-11
2026-11
2027-02

Reported research facilities

CMAX Clinical ResearchAdelaide, South Australia, Australia · Coordinates available
CMAX Clinical Research Pty LtdAdelaide, South Australia, Australia · Coordinates available
Hadassah Medical Organization, Jerusalem, IsraelJerusalem, Israel · Coordinates available
Johns Hopkins School of MedicineBaltimore, Maryland, United States · Coordinates available
University of California, San FranciscoSan Francisco, California, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.